(VIANEWS) – VISTIN PHARMA (VISTN.OL) is among this list of stock assets with the highest dividend rate and return on equity on the Healthcare sector.
| Financial Asset | Price | Forward Dividend Yield | Return on Equity |
|---|---|---|---|
| VISTIN PHARMA (VISTN.OL) | kr23.60 | 3.13% | 16.03% |
| VIRBAC (VIRP.PA) | €336.50 | 0.49% | 13.8% |
Several Euronext companies pay out dividends to its shareholders. The dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.
1. VISTIN PHARMA (VISTN.OL)
3.13% Forward Dividend Yield and 16.03% Return On Equity
Vistin Pharma ASA, through its subsidiary, Vistin Pharma AS, produces and sells active pharmaceutical ingredients (APIs) worldwide. It offers metformin HCl APIs and direct compressive granulates for the pharmaceutical industry. The company was founded in 1969 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, VISTIN PHARMA has a trailing twelve months EPS of kr1.
PE Ratio
VISTIN PHARMA has a trailing twelve months price to earnings ratio of 23.6. Meaning, the purchaser of the share is investing kr23.6 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.03%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 30.8%, now sitting on 438.54M for the twelve trailing months.
Volume
Today’s last reported volume for VISTIN PHARMA is 8413 which is 33.34% below its average volume of 12622.
More news about VISTIN PHARMA.
2. VIRBAC (VIRP.PA)
0.49% Forward Dividend Yield and 13.8% Return On Equity
Virbac SA manufactures and sells a range of products and services for companion animals and farm animals in France, Europe, Latin America, North America, Asia, Pacific, and Africa and the Middle East. The company offers a range of vaccines, dental hygiene, reproduction, dermatology, parasiticides, diagnostic, antibiotics, and aquaculture products; and veterinary medicines for anesthesia, geriatrics, behavior, and injectable micronutrients, as well as petfood and electronic identification. It serves veterinarians, farmers, and pet owners. Virbac SA was founded in 1968 and is headquartered in Carros, France.
Earnings Per Share
As for profitability, VIRBAC has a trailing twelve months EPS of €14.14.
PE Ratio
VIRBAC has a trailing twelve months price to earnings ratio of 23.8. Meaning, the purchaser of the share is investing €23.8 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.8%.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Jun 26, 2023, the estimated forward annual dividend rate is 1.32 and the estimated forward annual dividend yield is 0.49%.
Yearly Top and Bottom Value
VIRBAC’s stock is valued at €336.50 at 06:30 EST, higher than its 52-week high of €314.00.
Volatility
VIRBAC’s last week, last month’s, and last quarter’s current intraday variation average was a positive 0.34%, a negative 0.30%, and a positive 1.10%.
VIRBAC’s highest amplitude of average volatility was 0.57% (last week), 0.80% (last month), and 1.10% (last quarter).
More news about VIRBAC.
